Establishment of the Western Japan Psoriasis Registry and first cross-sectional analysis of registered patients

Medicine & Life Sciences

• Psoriasis 100%
• Japan 83%
• Registries 80%
• Cross-Sectional Studies 66%
• apremilast 17%
• Deltaretrovirus Antibodies 16%
• Comorbidity 15%
• Etretinate 15%
• Body Mass Index 14%
• Hepatitis B Antibodies 13%
• Clinical Trials 13%
• Interleukin-23 12%
• Tumor Necrosis Factor Inhibitors 12%
• Psoriatic Arthritis 12%
• Hepatitis C Antibodies 12%
• Morbid Obesity 11%
• Dermatologists 11%
• Patient Reported Outcome Measures 11%
• Interleukin-17 10%
• Hepatitis B Surface Antigens 10%
• Interleukin-12 10%
• Hyperlipidemias 10%
• Biological Products 9%
• Informed Consent 9%
• Methotrexate 9%
• Hepatitis B virus 9%
• General Hospitals 9%
• Cyclosporine 9%
• Arthritis 8%
• Therapeutics 8%
• University Hospitals 7%
• Hypertension 6%
• Physicians 6%
• Safety 5%
• Incidence 4%